The outpatient EMR revenue path I would measure before claiming growth

Krasyn is an AI-native outpatient EMR. I am not going to claim growth from a new page, a pitch deck, or a better valuation story.

The cleaner test is whether real outpatient group practices move through a measurable buyer path:

1. a group-practice fit review starts,
2. the practice has a real workflow and team size,
3. the plan commitment is captured without patient data,
4. activation and retention can be measured after signup,
5. revenue events can be tied back to the source that produced them.

That is the path we are measuring now.

Why outpatient group practices?

A solo user can validate usability, but a group practice validates operational value: multiple providers, handoffs, scheduling, notes, chart review, billing-adjacent workflows, and admin oversight.

For a small outpatient group, the buying question is not "does this have every enterprise feature?" It is:

• can the team understand the system quickly?
• can clinicians review AI-assisted notes safely?
• can the practice see where time is saved or risk is reduced?
• can the subscription be justified by real team usage?

That is a better signal than generic traffic.

What we are not claiming

We are not claiming clinical validation, regulatory certification, or a medical outcome improvement from this post.

We are also not claiming a valuation increase from marketing copy. A valuation claim needs real evidence: qualified interest, paid conversion, activation, retention, and revenue.

What a useful fit review should answer

For an outpatient group practice, a useful first conversation should answer:

• specialty and practice size,
• provider count,
• whether the team is replacing an existing EMR or starting fresh,
• the first workflow they would need to trust,
• whether AI note review, scheduling, or admin workflow is the first pain point,
• whether there is a realistic paid plan fit.

No patient details are needed for that.

The current measurable path

If you run or help operate an outpatient group practice and want to evaluate this path, start here:

Request a Krasyn group-practice fit review

If you just want to see the public product surface first:

Visit Krasyn

The bar for calling it growth

Publishing this post is not growth by itself.

The bar is objective movement in the funnel:

• fit-review starts,
• legitimate inquiries,
• trials or demos,
• purchase events,
• activation evidence,
• retention evidence.

If those do not move, the honest answer is that the content did not produce growth.

That is the point of measuring it.